A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma [Corrigendum]
Liu Y, Sheng L, Hua H, Zhou J, Zhao Y, Wang B. Cancer Manag Res. 2023;15:651–666. The authors have advised Table 2 on pages 654-656, is incorrect. The correct Table 2 is as follows. Table 2 Baseline characteristics of patients Page 663, Figure 6 caption, the text “(D) OS of B...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-09-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/corrigendum-a-novel-and-validated-inflammation-based-prognosis-score-i-peer-reviewed-fulltext-article-CMAR |
| _version_ | 1797690503173505024 |
|---|---|
| author | Liu Y Sheng L Hua H Zhou J Zhao Y Wang B |
| author_facet | Liu Y Sheng L Hua H Zhou J Zhao Y Wang B |
| author_sort | Liu Y |
| collection | DOAJ |
| description | Liu Y, Sheng L, Hua H, Zhou J, Zhao Y, Wang B. Cancer Manag Res. 2023;15:651–666.
The authors have advised Table 2 on pages 654-656, is incorrect. The correct Table 2 is as follows.
Table 2 Baseline characteristics of patients
Page 663, Figure 6 caption, the text “(D) OS of BCL2 ≥50%; (E) OS of MYC ≥40%” should read “(D) OS of MYC ≥40%; (E) OS of BCL2 ≥50%”.
The authors apologize for these errors and advise they do not affect the results of the paper. |
| first_indexed | 2024-03-12T02:00:29Z |
| format | Article |
| id | doaj.art-a9e0665b28d242ee96a409d515a06998 |
| institution | Directory Open Access Journal |
| issn | 1179-1322 |
| language | English |
| last_indexed | 2024-03-12T02:00:29Z |
| publishDate | 2023-09-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Cancer Management and Research |
| spelling | doaj.art-a9e0665b28d242ee96a409d515a069982023-09-07T19:14:38ZengDove Medical PressCancer Management and Research1179-13222023-09-01Volume 15999100186506A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma [Corrigendum]Liu YSheng LHua HZhou JZhao YWang BLiu Y, Sheng L, Hua H, Zhou J, Zhao Y, Wang B. Cancer Manag Res. 2023;15:651–666. The authors have advised Table 2 on pages 654-656, is incorrect. The correct Table 2 is as follows. Table 2 Baseline characteristics of patients Page 663, Figure 6 caption, the text “(D) OS of BCL2 ≥50%; (E) OS of MYC ≥40%” should read “(D) OS of MYC ≥40%; (E) OS of BCL2 ≥50%”. The authors apologize for these errors and advise they do not affect the results of the paper.https://www.dovepress.com/corrigendum-a-novel-and-validated-inflammation-based-prognosis-score-i-peer-reviewed-fulltext-article-CMARdiffuse large b-cell lymphomainflammatory indicatorsoverall survivalprediction model |
| spellingShingle | Liu Y Sheng L Hua H Zhou J Zhao Y Wang B A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma [Corrigendum] Cancer Management and Research diffuse large b-cell lymphoma inflammatory indicators overall survival prediction model |
| title | A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma [Corrigendum] |
| title_full | A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma [Corrigendum] |
| title_fullStr | A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma [Corrigendum] |
| title_full_unstemmed | A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma [Corrigendum] |
| title_short | A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma [Corrigendum] |
| title_sort | novel and validated inflammation based prognosis score ibps predicts outcomes in patients with diffuse large b cell lymphoma corrigendum |
| topic | diffuse large b-cell lymphoma inflammatory indicators overall survival prediction model |
| url | https://www.dovepress.com/corrigendum-a-novel-and-validated-inflammation-based-prognosis-score-i-peer-reviewed-fulltext-article-CMAR |
| work_keys_str_mv | AT liuy anovelandvalidatedinflammationbasedprognosisscoreibpspredictsoutcomesinpatientswithdiffuselargebcelllymphomacorrigendum AT shengl anovelandvalidatedinflammationbasedprognosisscoreibpspredictsoutcomesinpatientswithdiffuselargebcelllymphomacorrigendum AT huah anovelandvalidatedinflammationbasedprognosisscoreibpspredictsoutcomesinpatientswithdiffuselargebcelllymphomacorrigendum AT zhouj anovelandvalidatedinflammationbasedprognosisscoreibpspredictsoutcomesinpatientswithdiffuselargebcelllymphomacorrigendum AT zhaoy anovelandvalidatedinflammationbasedprognosisscoreibpspredictsoutcomesinpatientswithdiffuselargebcelllymphomacorrigendum AT wangb anovelandvalidatedinflammationbasedprognosisscoreibpspredictsoutcomesinpatientswithdiffuselargebcelllymphomacorrigendum AT liuy novelandvalidatedinflammationbasedprognosisscoreibpspredictsoutcomesinpatientswithdiffuselargebcelllymphomacorrigendum AT shengl novelandvalidatedinflammationbasedprognosisscoreibpspredictsoutcomesinpatientswithdiffuselargebcelllymphomacorrigendum AT huah novelandvalidatedinflammationbasedprognosisscoreibpspredictsoutcomesinpatientswithdiffuselargebcelllymphomacorrigendum AT zhouj novelandvalidatedinflammationbasedprognosisscoreibpspredictsoutcomesinpatientswithdiffuselargebcelllymphomacorrigendum AT zhaoy novelandvalidatedinflammationbasedprognosisscoreibpspredictsoutcomesinpatientswithdiffuselargebcelllymphomacorrigendum AT wangb novelandvalidatedinflammationbasedprognosisscoreibpspredictsoutcomesinpatientswithdiffuselargebcelllymphomacorrigendum |